Immediate Impact
68 standout
Citing Papers
Reteplase versus Alteplase for Acute Ischemic Stroke
2024 Standout
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
2023 Standout
Works of Christopher Bode being referenced
Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos
2021
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Bode | 222 | 320 | 40 | 124 | 27 | 552 | |
| Pauline M. Dobson | 208 | 161 | 22 | 29 | 18 | 476 | |
| David Gerber | 85 | 124 | 21 | 30 | 40 | 577 | |
| Sandrine Alonso | 228 | 54 | 42 | 18 | 56 | 608 | |
| Serge Dubé | 234 | 136 | 61 | 69 | 15 | 482 | |
| Jon W. Schrock | 125 | 206 | 80 | 105 | 35 | 599 | |
| Elliot Long | 211 | 90 | 27 | 43 | 40 | 600 | |
| Alexis Cerisier | 263 | 410 | 20 | 98 | 35 | 605 | |
| Geoffrey E. Hayden | 252 | 147 | 27 | 101 | 26 | 553 | |
| Jos Twisk | 120 | 321 | 36 | 285 | 15 | 637 | |
| Amandeep Singh | 139 | 86 | 19 | 33 | 33 | 461 |
All Works
Loading papers...